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Satellite gliaNeural crest cells and oligodendrocytes as the myelinating glia of the central nervous system exist only in
vertebrates. Their development is regulated by complex regulatory networks, of which the SoxE-type high-
mobility-group domain transcription factors Sox8, Sox9 and Sox10 are essential components. Here we
analyzed by in ovo electroporation in chicken and by gene replacement in the mouse whether the Drosophila
ortholog Sox100B can functionally substitute for vertebrate SoxE proteins. Sox100B overexpression in the
chicken neural tube led to the induction of neural crest cells as previously observed for vertebrate SoxE
proteins. Furthermore, many aspects of neural crest and oligodendrocyte development were surprisingly
normal in mice in which the Sox10 coding information was replaced by Sox100B arguing that Sox100B
integrates well into the gene-regulatory networks that drive these processes. Our results therefore provide
strong evidence for a model in which SoxE proteins were co-opted to these gene-regulatory networks mainly
through the acquisition of novel expression patterns. However, later developmental defects in several neural
crest derived lineages in mice homozygous for the Sox100B replacement allele indicate that some degree of
functional specialization and adaptation of SoxE protein properties have taken place in addition to the co-
option event.(M. Wegner).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Proteins of the Sox family of transcription factors are found in all
metazoans (Guth and Wegner, 2008). Vertebrates and invertebrates
share a highly conserved set of Sox proteins belonging to the SoxB,
SoxC, SoxD, SoxE and SoxF subgroups, with fewer members of each
subgroup usually present in invertebrates compared to vertebrates.
The SoxE subgroup, for example, consists of single proteins in
Drosophila melanogaster and Caenorhabditis elegans, whereas it
contains three members (Sox8, Sox9 and Sox10) in all tetrapods
and even more in teleosts due to an additional whole genome
duplication.
The SoxE protein Sox10 has essential functions in early neural crest
development, in the ensuing development of many cell types from the
neural crest and in oligodendrocyte development (Britsch et al., 2001;
Herbarth et al., 1998; Kapur, 1999; Kim et al., 2003; Southard-Smith
et al., 1998; Stolt et al., 2002). In Sox10-deﬁcient mice, survival ofearly neural crest cells is decreased (Kapur, 1999; Kim et al., 2003).
Additionally, neural crest-derived melanocytes of the skin and
chromafﬁn cells of the adrenal medulla are not formed (Britsch
et al., 2001; Reiprich et al., 2008; Southard-Smith et al., 1998). Many
parts of the peripheral nervous system (PNS) are also affected. The
nervous system of the gut (ENS) is completely missing, sympathetic
ganglia are strongly reduced in size and no glial cells are formed in any
part of the PNS (Britsch et al., 2001; Herbarth et al., 1998; Kapur, 1999;
Kim et al., 2003; Reiprich et al., 2008; Southard-Smith et al., 1998). As
a consequence, Sox10-deﬁcient mice die before or at birth.
Oligodendrocytes as the myelin-forming cells of the central
nervous system (CNS) are one of the few non-neural crest-derived
cell types that express Sox10. Although Sox10 has functions both in
oligodendrocyte precursors and mature oligodendrocytes (Finzsch
et al., 2008), generation of oligodendrocyte precursors is not affected
in Sox10-deﬁcient mice. Loss of Sox10, however, interferes with
terminal oligodendrocyte differentiation and the production of
myelin (Stolt et al., 2002).
Both the neural crest and oligodendrocytes have arisen only in
vertebrate lineages during evolution and represent synapomorphies.
The emergence of the neural crest is proposed to be a key factor
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basal chordate body plan, in particular the head, in a manner that
allowed a shift from ﬁlter feeding to an active predatory lifestyle
(Gans and Northcutt, 1983). With their myelin sheath oligodendro-
cytes provide the structural basis for rapid saltatory conductance
within the CNS which in turn represents an essential precondition for
the evolution of complex brains (Zalc et al., 2008).
Currently it is unclear how these cell types arose during evolution
(Baker, 2008). Studies on amphioxus, representing a basal chordate
without neural crest, and agnathans, basal vertebrates with neural
crest, indicate that the regulatory circuits that establish the neural
plate border were already in place in chordates but that those
responsible for neural crest induction are novel in vertebrates (Sauka-
Spengler et al., 2007; Yu et al., 2008). Two models are proposed to
explain how the components of the neural crest gene-regulatory
network, the so-called neural-crest speciﬁers, were recruited. It may
be envisaged that an existing regulatory protein ﬁrst underwent
structural mutations and changed its properties so that it became
suitable for a novel role in neural crest speciﬁcation. Alternatively, a
regulatory protein may have been primarily recruited through
changes in its expression pattern. In the second alternative, the
regulatory proteinmay have been co-opted alone or as part of a whole
regulatory circuit.
All three SoxE proteins including Sox10 are essential components
of the vertebrate-speciﬁc regulatory networks that drive neural crest
and oligodendrocyte development arguing that a common precursor
of these SoxE proteins was recruited to the regulatory networks in
early vertebrates. To explore how vertebrate SoxE proteins became
part of these networks and to better understand their role in the
evolution of neural crest cells and oligodendrocytes, we focused on
the Sox10 gene and compared its function with an invertebrate SoxE
gene in overexpression studies and after gene replacement in the
mouse. The chosen Sox100B gene from D. melanogaster is expressed in
many tissues during ﬂy development including hindgut, Malpighian
tubules, and gonad (Hui Yong Loh and Russell, 2000). Gonadal
expression is sexually dimorphic with Sox100B being speciﬁcally
expressed in two male-speciﬁc cell populations, the male-speciﬁc
somatic gonadal precursor cells and the pigment cell lineage (DeFalco
et al., 2008, 2003). Sox100B-deﬁcient ﬂies have no discernible
embryonic or larval phenotypes, but die as pharate adults. At this
time, ﬂies have severe abnormalities in their fat bodies and fail to
develop normal testes (Nanda et al., 2009). Sox100B exhibits very few
similarities in expression and function with vertebrate SoxE proteins,
which are furthermore restricted to the developing male gonad (Guth
and Wegner, 2008). Nevertheless, we show a surprising ability of
invertebrate Sox100B to compensate for Sox10 loss during neural
crest development and in oligodendrocyte differentiation. Co-option
of SoxE proteins through changed expression may thus have played a
decisive role in the appearance of neural crest cells and oligoden-
drocytes, before the co-opted SoxE protein was optimized for its new
functions through structural mutations.
Materials and methods
Construction of targeting vectors, gene targeting, generation and
genotyping of mouse mutants
Sequences corresponding to the open reading frame of Drosophila
Sox100B, an IRES-EGFP and a neomycin resistance cassette with
ﬂanking loxP sites were placed between 5′ and 3′ Sox10 genomic
regions as homology arms (4.3 kb and 1.5 kb respectively) in the
context of a pPNT vector backbone as described (Britsch et al., 2001;
Kellerer et al., 2006; Ludwig et al., 2004b). The targeting vector
thereby replaced the Sox10 coding exons by a continuous Sox100B
reading frame and a GFP coding sequence linked by an internal
ribosomal entry site (Fig. 3A).The construct was linearized with NotI and electroporated into
E14.1 ES cells which were then selected with G418 (400 µg per ml)
and gancyclovir (2 µM). Selected ES cell clones were screened by
Southern blotting with a 0.6 kb 5′ probe, which recognized a 6.6 kb
fragment in case of the wildtype allele and a 7.7 kb fragment in case of
the Sox10Sox100B allele in genomic DNA digested with NcoI (Fig. 3B).
Appropriate integration of the 3′ end of the targeting construct was
veriﬁed using a 0.6 kb 3′ probe on ES cell DNA digested with BamHI
and ScaI. This probe hybridized to a 5.4 kb fragment in the Sox10Sox100B
allele as opposed to a 4.6 kb fragment in the wildtype allele (Fig. 3B).
Targeted ES cells were injected into C57Bl/6J blastocysts to generate
chimeras. After germline transmission, heterozygous mice were
backcrossed on a C3H background. Homozygous mutant embryos
(F2–F5) were generated by heterozygote intercrosses. Sequencing of
genomic DNA from the altered Sox10 locus conﬁrmed that no
additional unintended mutations were introduced during cloning.
Genotyping was routinely performed on DNA from tail tips, or in
case of embryos from yolk sacs, by PCR analysis using a commonupper
primer located 81 bp upstream of the start codon (5′-CAGGTGGGCGT-
TGGGCTCTT-3′) and two lower primers located 487 bp downstreamof
the start codon in intron 3 of the Sox10 gene (5′-TCCCAGGCTAGCCC-
TAGTG-3′) or 582 bp downstream of the start codon in the Sox100B
open reading frame (5′-CGCTCGCCTCTGGCCATTGG-3′). A 568 bp
fragment was indicative of the wildtype allele, a 663 bp fragment of
the targeted allele (Fig. 3C).
Chicken in ovo electroporation
Fertilized chicken eggs were obtained from Lohmann (Cuxhaven,
Germany) and incubated in a humidiﬁed incubator at 37.8 °C.
Embryos were staged according to Hamburger and Hamilton (HH)
(Hamburger and Hamilton, 1953). pCAGGS-IRES-nls-GFP and
pCAGGS-IRES-nls-GFP-based expression plasmids for Drosophila
Sox100B and rat Sox10 were injected at a concentration of 2 µg/µl
into the lumen of HH stage 10–11 neural tubes. Electrodes were
placed at either side of the neural tube and electroporation was
carried out using a BTX ECM830 electroporator delivering ﬁve
50 millisecond pulses of 30 V. Transfected embryos were allowed to
develop for 48 h before dissection and analysis.
Tissue and RNA preparation from embryos, in situ hybridization,
immunohistochemistry and quantitative RT-PCR
Mouse embryos were isolated at 10.5 dpc to 18.5 dpc from staged
pregnancies and chicken embryos 48 h after electroporation. Subse-
quently, embryos were processed for RNA preparation, immunohis-
tochemistry or in situ hybridization (Kellerer et al., 2006; Stolt et al.,
2004, 2003).
Each immunohistochemistry and in situ hybridization was
performed at least three times on at least three embryos per genotype.
In situ hybridizations (except probe hybridization and ﬁnal colori-
metric detection) were performed automatically on a Biolane HTI
(Hölle & Hüttner AG) using DIG-labelled antisense riboprobes for
chicken FoxD3 (a gift fromM. Goulding, Salk Institute, La Jolla; Dottori
et al., 2001) and for mouseMBP,Mitf and Dct (Britsch et al., 2001; Stolt
et al., 2002).
Primary antibodies for immunohistochemistry included: anti-Sox8
guinea pig antiserum (1:1000 dilution, Stolt et al., 2005), anti-Sox10
guinea pig antiserum (1:2000 dilution, Maka et al., 2005), anti-Sox10
rabbit antiserum (1:100 dilution; Stolt et al., 2003), anti-Sox9 rabbit
antiserum (1:1000 dilution, Stolt et al., 2003), anti-Sox100B rabbit
antiserum (1:2000 dilution, Hui Yong Loh and Russell, 2000), anti-
Phox2b rabbit antiserum (1:2000 dilution, a gift from C. Goridis, Ecole
Normale Superieure, Paris), anti-Olig2 rabbit antiserum (1:10,000
dilution, a gift from D. Rowitch, UCSF, San Francisco), anti-B-FABP
rabbit antiserum, (1:10,000 dilution, a gift from C. Birchmeier and T.
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Biomol), anti-steroidogenic factor-1 (SF-1) rabbit antiserum (1:1000
dilution; a gift from K. Morohashi, National Institute for Basic Biology,
Japan), anti-Krox20 rabbit antiserum (1:1000 dilution, Covance), anti-
Oct6 rabbit antiserum (1:2000, Friedrich et al., 2005), anti-Sox5 rabbit
serum (1:4000, Perez-Alcala et al., 2004), anti-Tubb3 mouse mono-
clonal (1:5,000 dilution; Covance), anti-NeuN mouse monoclonal
(1:500 dilution, Chemicon), anti-laminin mouse monoclonal (1:3000,
Developmental Studies Hybridoma Bank), anti-HNK1 mouse mono-
clonal (1:10,000, BD Pharmingen), anti-Cad7 (1:200 Developmental
Studies Hybridoma Bank). Secondary antibodies conjugated to Cy3,
Cy2 or Alexa ﬂuor immunoﬂuorescent dyes (Dianova and Molecular
Probes)were used for detection. Dissected gastrointestinal tractswere
also used for NADPHdiaphorase staining (Scherer-Singler et al., 1983).
Samples were analyzed and documented as described (Kellerer et al.,
2006).
For quantitativeRT-PCR,whole embryoRNAwas reverse transcribed
in a 20 µl reaction, before 1 µl of the obtained cDNA, diluted 1 to 5, was
ampliﬁed by PCRon aRoche Lightcycler according to themanufacturer's
instructions using the LightCycler-FastStart DNAMaster SYBRGreen kit.
The following primer pairs were used: Primers 5′-ACAGCAGCAG-
GAAGGCTTCT-3′ and 5′-TGTCCTCAGTGCGTCCTTAG-3′ for detection of
Sox10, primers 5′-CTACTCCTACCCCGCAAACG-3′ and 5′-AGGGATTGA-
CATAAGTGTAA-3′ for detection of Sox100B, primers 5′-TCAGTCTCG-
GCTGTCCAGCC-3′ and 5′-GAAGAGCCCAACGCCACCT-3′ for detection of
both Sox10 and Sox100B, primers 5′-TGGAGTCTGGTGCCTATGCCTGT-3′
and 5′-GCCGAGCACTGCATCAGCTTTGT-3′ for detection of Sox8 and
primers 5′-GAACAGACTCACATCTCTCC-3′ and 5′-TGCTGCTTCGACATC-
CACAC-3′ for detection of Sox9. Rpl8 transcripts were used for
normalization (Kellerer et al., 2006). The annealing temperature was
64 °C.
Cell culture, analysis of protein stability, gel retardation and luciferase
assays
B16 melanoma, Neuro2a neuroblastoma and human embryonic
kidney 293 cells were maintained in DMEM containing 10% FCS, and
transfected using either polyethylenimine (PEI) or Superfect reagent
(Qiagen, Hilden, Germany).
For analysis of protein stability, B16 melanoma cells were
transfected with pCAGGS-IRES-nls-GFP based expression plasmids
for myc-tagged Sox10 or myc-tagged Sox100B using PEI reagent and
treated 48 h after transfection with 25 µg/ml cycloheximide for up to
24 h. Extracts were prepared after various times of cycloheximide
treatment, and both ectopically expressed proteins were detected by
western blot. Sox10- and Sox100B-speciﬁc bands on western blots
were quantiﬁed using the NIH ImageJ software.
For gel retardation assays, 293 cells were transfected with pCMV5
based expression plasmids for shortened variants of Sox10 (amino
acids 1–189) and Sox100B (amino acids 1–162) using PEI reagent. Cell
extracts were prepared 48 h posttransfection and incubated sepa-
rately or after mixing with 32P-labelled oligonucleotides containing
the prototypic dimeric site C/C′ or monomeric site B from the Mpz
gene in the presence of poly(dGdC) as unspeciﬁc competitor before
polyacrylamide gel electrophoresis and autoradiographic exposure of
the dried gels (Peirano et al., 2000).
For luciferase assays, Neuro2a and B16 cells were transfected
transiently in duplicates using Superfect reagent in 3.5-cm dishes
with 500 ng of luciferase reporter and 500 ng of effector plasmids per
dish. Luciferase reporters were used that contained theMitf promoter
(positions−1486 to +97, Bondurand et al., 2000), the Dct promoter
(positions−685 to +443, Ludwig et al., 2004a) or the Mpz promoter
(positions −435 to +48, Peirano et al., 2000). Effector plasmids
corresponded to pCAGGS-IRES-nls-GFP based expression plasmids for
Sox10 or Sox100B. Cells were harvested 48 h posttransfection, and
extracts were assayed for luciferase activity. Luciferase activitiesobtained with the different effectors were normalized to luciferase
activity observed with pCAGGS-IRES-nls-GFP alone. Bar graphs
usually result from three duplicates and the S.E.M. is shown as error
bar.
Results
Comparison of sequences and biochemical properties between mouse
Sox10 and Sox100B from Drosophila
Mammalian SoxE proteins possess four different regions that have
been functionally characterized. These include a region that imme-
diately precedes the DNA-binding high-mobility-group (HMG)
domain and has been deﬁned as a dimerization domain (Peirano
and Wegner, 2000; Schlierf et al., 2002), the HMG domain itself, a
context-dependent transactivation domain K2 (Schepers et al., 2000;
Schreiner et al., 2007) and a carboxy-terminal transactivation domain
TA (Kuhlbrodt et al., 1998; Pusch et al., 1998; Südbeck et al., 1996)
(Fig. 1A). The dimerization and DNA-binding domains are highly
conserved at the amino acid level, whereas conserved amino acid
residues are particularly prominent at the amino-terminal and
carboxy-terminal ends of the K2 domain and the carboxy-terminal
end of the TA domain.
To assess the degree of sequence conservation between Sox100B
and the mammalian SoxE proteins, we performed an alignment of all
four amino acid sequences using the TCoffee tool (Poirot et al., 2003)
(Fig. 1B). Even after inclusion of Sox100B, the HMG domain remains
very similar (71% amino acid identity, 91% amino acid similarity) and
the dimerization domain retains a core of conserved amino acid
residues. In contrast, the K2 and TA domains are not apparent in
Sox100B, at least by sequence conservation.
To study the biochemical properties of Sox100B, we ﬁrst
determined its stability in transfected cycloheximide-treated B16
melanoma cells and found it comparable to Sox10, with half lives of
approximately 2 h for both proteins (Fig. 1C). The DNA-binding ability
of Sox100B was analyzed by using the well-characterized Sox10
recognition sites B and C/C′ from the Mpz gene as probes in gel
retardation assays (Peirano et al., 2000). Both sites were efﬁciently
bound by Sox100B (Fig. 1D). Complexes of Sox100B with site B and
site C/C′ exhibited different mobilities which as in the case of Sox10 is
indicative of monomeric binding to site B and dimeric binding to site
C/C′ (Peirano et al., 2000). Joint incubation of site C/C′with Sox10 and
Sox100B furthermore led to the appearance of an additional complex
with amobility that was intermediate between the Sox10-speciﬁc and
the Sox100B-speciﬁc complexes and corresponds to a heterodimer
(Fig. 1D). Sox100B thus efﬁciently binds to both monomeric and
dimeric recognition sites of vertebrate SoxE proteins arguing that the
limited degree of Sox100B conservation to the dimerization domain of
mammalian SoxE proteins is functionally relevant.
Considering the similar protein stabilities and DNA-binding
properties, we asked whether Sox100B is able to activate promoters
of mammalian SoxE target genes in cell culture. We focused on the
Sox10 target genesMpz,Mitf and Dct (Bondurand et al., 2000; Ludwig
et al., 2004a; Peirano et al., 2000). In luciferase reporter gene assays all
three promoters were efﬁciently activated by Sox100B independent of
whether Neuro2a neuroblastoma was used or B16 melanoma cells
(Figs. 1E–I). Sox100B is thus capable of activating mammalian SoxE
target genes despite the low degree of sequence conservation in K2
and TA domains. However, it has to be kept in mind that luciferase
reporter gene assays in transiently transfected cells are very basal
assays that require veriﬁcation in vivo.
Sox100B electroporation into the early neural tube of chicken
To gain an initial impression of Sox100B activity in vivo, we used in
ovo electroporation to overexpress the Drosophila SoxE protein in the
Fig. 1. Structural and biochemical comparison of Sox100B with mammalian SoxE proteins. (A) General structure of a mammalian SoxE protein with dimerization (Dim), HMG, K2
and carboxy-terminal transactivation (TA) domains as functional regions. (B) Sequence comparison between the mouse SoxE proteins Sox8, Sox9 and Sox10 and Sox100B from
Drosophila melanogaster. Fully conserved amino acids are marked by an asterisk, closely related amino acids by two dots and biochemically similar ones by a single dot. (C) Protein
stability of Sox10 (blue circle) and Sox100B (red square). B16 melanoma cells were transiently transfected with myc-tagged Sox10 or myc-tagged Sox100B and cultured for various
times in the presence of cycloheximide as indicated. After extract preparation, ectopically expressed proteins were detected by western blots and relative amounts were quantiﬁed
from band intensities with the respective amount in untreated cells set to 100%. (D) Comparison of DNA-binding by Sox10 and Sox100B. Cell extracts containing Sox10 (amino acids
1–189) or Sox100B (amino acids 1–162) were separately or jointly incubated with a radioactively labelled oligonucleotide containing the prototypic dimeric C/C′ site or monomeric
B site from the Mpz gene (Peirano et al., 2000). Note that both Sox10 and Sox100B form a dimeric complex with C/C′ (d) whose mobility is lower than the respective monomeric
complex with B (m) and that joint incubation of C/C′ with Sox10 and Sox100B yields a novel complex (hd, marked by an arrowhead). (E–I) Transactivation capacity of Sox10 and
Sox100B. Transient transfections were performed in Neuro2a (E–G) and B16 (H,I) cells with luciferase reporters under the control of the Dct (E), the Mitf (F,H) or the Mpz (G,I)
promoter. Luciferase reporters were transfected alone, in the presence of Sox10, Sox100B or a combination of both as effectors. Data are presented as fold induction, with the
luciferase activity obtained for each construct in the absence of effector arbitrarily set to 1±S.E.M.
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Fig. 2. Sox100B overexpression in early chicken spinal cord development. Chicken embryos were electroporated with pCAGGS-IRES-nls-GFP expression plasmids that contained no
additional coding information (A,D,G,J,M) or open reading frames for Sox10 (B,E,H,K,N) or Sox100B (C,F,I,L,O). Fixation was 48 h after the electroporation event. Shown are transverse
sections with the electroporated side oriented to the left and marked by GFP autoﬂuorescence (in green). Immunohistochemistry (in red) against laminin (A–C), HNK1 (D–F),
cadherin-7 (Cad7) (G–I) and Sox5 (J–L) was performed and overlaid with the GFP autoﬂuorescence signal. In situ hybridizations with a FoxD3-speciﬁc antisense riboprobe were
additionally carried out (M–O). Arrowheads point to cells with induced FoxD3 expression. Scale bar in A is valid for all panels and corresponds to 100 µm. (P–R) The percentage of
electroporated cells expressing HNK1 (P), cadherin-7 (Q) or Sox5 (R) was determined for control (Gfp), Sox10 and Sox100B electroporations. Sections from ﬁve embryos were
quantiﬁed for each electroporated construct and data are presented as mean±SEM. The percentage of control-electroporated cells expressing HNK1, cadherin-7 or Sox5 was
signiﬁcantly lower than the percentages of SoxE-electroporated cells as determined by one-way analysis of variance (ANOVA) with Tukey's multiple comparison post-test
(***, Pb0.001). No statistically signiﬁcant difference was detected between Sox10 and Sox100B electroporations.
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have previously been shown to induce neural crest characteristics in
neural tube cells with only minor differences (Cheung and Briscoe,
2003; McKeown et al., 2005). By comparing control-electroporated
with Sox10-electroporated cells, neural crest inducing activity
becomes evident. Only Sox10-electroporated cells migrated out of
the neural tube and disrupted the surrounding extracellular matrix
(Perez-Alcala et al., 2004) (compare Figs. 2A,D,G,J to B,E,H,K). 73–94%
of Sox10-electroporated cells furthermore expressed neural crest
markers such as HNK1, cadherin-7 and Sox5 (Figs. 2E,H,K,P,Q,R)Fig. 3. Targeted replacement of Sox10 by Sox100B sequences in mice. (A) Schematic represen
the Sox10 wildtype locus and the mutant locus. The Sox10 exons (I–V) and the Sox100B open
Regions of homology between wildtype locus and targeting vector are depicted as black ba
targeting construct as stippled bars. Plasmid backbone sequences of the targeting construct
shown as well as the localization of 5′ and 3′ probes and the start codon of the Sox10 gene (A
Herpes simplex virus thymidine kinase gene cassette. (B) Southern blot analysis of DNA from
5′ probe and BamHI/ScaI for the 3′ probe. The size of bands corresponding to the wildtype (6
5′ probe and 5.4 kb for the 3′ probe) is indicated. (C) PCR genotyping of wildtype (WT),
18.5 dpc. DNA fragments in the sizemarker (M) are 1.0 kb and 0.5 kb. (D) GFP autoﬂuorescen
bar corresponds to 1 mm. (E) Immunoﬂuorescence on transverse sections of 10.5 dpc-old
against Sox100B (left) and Sox10 (right). Scale bar corresponds to 100 µm.compared to 13–31% of control-electroporated cells (Figs. 2D,G,J,P,Q,R).
When Sox100B was electroporated into the chicken neural tube,
cells leaving the neural tube were detected and laminin staining
revealed that the extracellular matrix surrounding the neural tube
was no longer intact on the electroporated side (Fig. 2C). The
percentage of Sox100B-electroporated cells expressing HNK1
(Figs. 2F,P), cadherin-7 (Figs. 2I,Q) and Sox5 (Figs. 2L,R) ranged
between 82% and 94% arguing that Sox100B activated neural crest
markers as efﬁciently as Sox10. In accord, FoxD3 expression was
induced comparably after electroporation of Sox100B and Sox10tation from top to bottom of the targeting construct for the Sox100B replacement allele,
reading frame are shown as boxes, the 4.3 kb and 1.5 kb long ﬂanking regions as bars.
rs, introns 3 and 4 as open bars and surrounding genomic regions not contained in the
are indicated by a thin line. Restriction sites for NcoI (N), BamHI (H) and ScaI (S) are
TG). neo, neomycin resistance cassette; loxP, recognition sites for Cre recombinase; Tk,
wildtype (wt) and heterozygous (+/Sox100B) ES cells digested with NcoI for use of the
.6 kb for the 5′ probe and 4.6 kb for the 3′ probe) and the targeted alleles (7.7 kb for the
heterozygous (+/Sox100B) and homozygous (Sox100Β/Sox100B) mouse embryos at
ce of Sox10Sox100B/Sox100B, Sox10+/Sox100B andwildtype (WT) embryos at 10.5 dpc. Scale
wildtype embryos (WT) and Sox10Sox100B/Sox100B littermates with antibodies directed
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SoxE proteins, including Sox10, regarding neural crest induction in this
in vivo overexpression system.
Generation of Sox100B expressing mice
Sox100B protein levels are very high in electroporated cells and
overexpression takes place in a background in which endogenous
SoxE genes are present. Considering, that Sox9 can induce Sox10
expression (Cheung et al., 2005), it cannot be ruled out that Sox100B
simply activates the expression of endogenous SoxE proteins which in
turn may be responsible for inducing neural crest properties.
To analyze the functional properties under more physiological
conditions, we chose to generate amousemodel inwhichwe replaced
Sox10 with Sox100B by exchanging the complete coding region of
Sox10 in exons 3–5 with a Sox100B cDNA (Fig. 3A). The Sox100B start
codon was placed exactly at the position of the endogenous Sox10
start codon in exon 3. This strategy has been previously employed to
replace Sox10 sequences with various marker genes, Sox8, or mutant
Sox10 sequences (Britsch et al., 2001; Kellerer et al., 2006; Ludwig
et al., 2004b; Schreiner et al., 2007). Mutant Sox10 sequences coded
for proteins without dimerization domain (Sox10aa1) or without K2
domain (Sox10ΔK2), the very same domains that are only partially or
very poorly conserved in Sox100B. These studies showed that
expression levels of the inserted cDNA correspond closely to
expression levels of the Sox10 gene in the wildtype (Kellerer et al.,
2006; Ludwig et al., 2004b; Schreiner et al., 2007). Re-application of
the same strategy thus increased the likelihood that Sox100B
expression levels would also be in a physiologically relevant range.
It also ensured that phenotypic comparison of the novel with the
previous mouse mutants would allow meaningful conclusions about
the rescuing capacity of Sox100B relative to those of Sox8 and the
various Sox10 mutants.
Using the targeting vector shown in Fig. 3A, ES cells were
electroporated and clones were identiﬁed that had successfully
undergone homologous recombination and carried a correctly
recombined Sox10 allele (Fig. 3B). After blastocyst injection, these
ES cells generated chimeras that transmitted the targeted allele to
their progeny (Fig. 3C). By studying expression of the GFPmarker that
was additionally introduced into the Sox10 locus and expressed fromFig. 4. Sox gene expression levels in Sox10Sox100B/Sox100B embryos. (A) Sox10-speciﬁc express
age-matched Sox10Sox100B/Sox100B embryos (KI) at 11.5 dpc following quantitative RT-PCR
determined in wildtype embryos (set to 1) as well as Sox10+/Sox100B (HET) and Sox10Sox10
both alleles equally. (C,D) Expression of Sox8 (C) and Sox9 (D) was quantiﬁed in Sox10Sox10
gene-speciﬁc RT-PCR. Expression levels were normalized to Rpl8 in all RT-PCR experimen
genotype. (E,F) The percentage of Sox8-positive cells (E) and Sox9-positive cells (F) was dete
three embryos were quantiﬁed per genotype and data are presented asmean±SEM. No statis
on spinal nerves (demarcated by dotted lines) of wildtype (G,I) and Sox10Sox100B/Sox100B (H
inlays represent results from co-immunohistochemistry with antibodies against Sox10 (G,I) o
to cells within the nerve that do not express Sox10 in the wildtype and Sox100B in the muthe same transcript as Sox100B due to the presence of an internal
ribosomal entry site (Fig. 3A), it is clear that the spatial and temporal
expression pattern of the targeted allele is identical to the wildtype
Sox10 expression pattern (Fig. 3D and data not shown) (Britsch et al.,
2001). Immunohistochemistry with antibodies directed against Sox10
and Sox100B revealed that Sox10 protein was completely replaced by
Sox100B in homozygous mutant embryos (Fig. 3E). Signal intensities
for Sox10 and Sox100B were furthermore indistinguishable on the
single cell level arguing for comparable amounts of both proteins per
cell in the respective genotypes.
In support of this conclusion, Sox100B transcript levels in homo-
zygous mutant embryos were similar to Sox10 transcript levels in
wildtype embryos at 11.5 dpc as determined by quantitative RT-PCR
(Fig. 4A). Likewise, no statistically signiﬁcant differences were
detected between transcript levels in wildtype, heterozygous and
homozygous mutant embryos when primers were used that equally
recognizedwildtype andmutant transcripts (Fig. 4B). Levels were also
comparable between genotypes for Sox8 and Sox9 transcripts
(Figs. 4C,D) and proteins. Immunohistochemistry on spinal nerves
with antibodies directed against Sox8 or Sox9, for instance, yielded
comparable numbers of positive cells (Figs. 4E,F) and similar staining
intensities (Figs. 4G–J) in wildtype and homozygous mutant embryos
at 18.5 dpc. Sox8 and Sox9 were not expressed in Sox10-positive cells
of wildtype nerves nor in Sox100B-positive cells of mutant nerves
(see inlays in Figs. 4G–J) arguing that Sox8 and Sox9 are not
upregulated by Sox100B expression in Schwann cells. We conclude
that Sox100B is expressed in the mutant at levels comparable to
Sox10 in thewildtype and does not exert unforeseen inﬂuences on the
expression of other SoxE family members.
Both heterozygous and homozygous embryos were obtained at all
ages (Fig. 3C). GFP autoﬂuorescence and Sox100B immunohisto-
chemistry in homozygous embryos furthermore showed that neural
crest cells were formed and migrated to their target tissues in a
spatially and temporally normal manner in cranial, vagal, trunk, and
sacral regions (Figs. 3D,E and data not shown). This conﬁrms that
Sox100B efﬁciently provides Sox10 functions in the early neural crest.
However, homozygous newborns died immediately after birth
suggesting that later development of some neural crest derivatives
must be defective and that Sox100B and Sox10 are not fully equivalent
with regard to their function. Analyses are therefore restricted toion in wildtype embryos (WT, set to 1) was compared to Sox100B-speciﬁc expression in
with gene-speciﬁc primers. (B) Total expression levels from the Sox10 locus were
0B/Sox100B littermates at 11.5 dpc by quantitative RT-PCR using primers that recognize
0B/Sox100B embryos at 11.5 dpc relative to age-matched wildtype embryos (set to 1) by
ts. Experiments were repeated three times with material from two embryos for each
rmined along spinal nerves of wildtype and Sox10Sox100B/Sox100B embryos. Sections from
tically signiﬁcant differences were detected. (G–J) Immunoﬂuorescence was performed
,J) embryos at 18.5 dpc with antibodies directed against Sox8 (G,H) and Sox9 (I,J). The
r Sox100B (H,J) (both in green) and show that expression of Sox8 and Sox9 is restricted
tant. The scale bar in G corresponds to 50 µm and is valid for G–J.
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generation. Analyzed generations and genetic background were
identical to those in previous studies where Sox10 was replaced by
Sox8 or mutant Sox10 proteins (Kellerer et al., 2006; Schreiner et al.,
2007). No evidence was obtained from the analysis of PNS and CNS
development in mice with one Sox100B replacement allele and one
Sox10 null allele that Sox100B acts as a dominant-negative (data not
shown).
Ability of Sox100B to rescue melanocyte development in the absence of
Sox10
Even in early generations, heterozygous mice were easily detected
due to their white belly spot and a white medial stripe on the head,
arguing that melanocytes are one of the affected neural crest
derivatives. Sox10 is important for melanocyte development because
it induces Mitf in melanoblasts. When Mitf expression was studied in
mice homozygous for the Sox100B replacement allele, some Mitf-
positive cells were found in the vicinity of the eye and the hindlimb
region at 11.5 dpc (Fig. 5A). Few melanoblasts were also detected
with Dct as an alternative melanoblast marker in the hindlimb region
at 12.5 dpc (Fig. 5B), indicating that melanoblasts are speciﬁed from
the neural crest when Sox10 is replaced by Sox100B. However, inmice
homozygous for the Sox100B replacement allele, melanoblasts are
strongly reduced, arguing that the Drosophila ortholog is a much less
efﬁcient inducer of melanocytes than Sox10 despite its ability to
efﬁciently activate the promoters of the Sox10 target genes Mitf and
Dct in cell culture assays. Comparable reductions inmelanoblasts haveFig. 5. Melanocyte development in Sox10Sox100B/Sox100B embryos. Whole mount in situ
hybridizations were performed on wildtype (WT) and Sox10Sox100B/Sox100B (KI)
embryos at 11.5 dpc using antisense riboprobes against Mitf at 11.5 dpc (A) and Dct
at 12.5 dpc (B). Shown for each probe are representative in situ hybridizations from the
eye and from the hindlimb region. Scale bars in A and B are valid for all respective four
panels and correspond to 100 µm.
Fig. 6. Analysis of the ENS in Sox10Sox100B/Sox100B embryos. Stomach (A,B), duodenum
(C,D), jejunum (E,F) and caecum (G,H) of wildtype (WT, panels A,C,E,G) and
Sox10Sox100B/Sox100B (KI, panels B,D,F,H) embryos were analyzed at 18.5 dpc by
NADPH diaphorase staining. The scale bar in A is valid for all panels and corresponds
to 100 µm.previously been observed in mice where the Sox10 gene was replaced
by Sox8 (Kellerer et al., 2006) and in mice expressing the Sox10aa1
mutant (Schreiner et al., 2007). Mice expressing Sox10ΔK2, in
contrast, exhibited a slightly less severe reduction in melanoblasts
(Table 1).
Ability of Sox100B to rescue enteric nervous system development in the
absence of Sox10
Another neural crest derivative that was strongly affected in mice
with hypomorphic Sox10 alleles or a Sox8 replacement allele is the
enteric nervous system (ENS) (Kellerer et al., 2006; Schreiner et al.,
2007). In Sox100B replacement mice, the ENS formed normally in the
stomach (Figs. 6A,B). Even the duodenum was signiﬁcantly colonized
by enteric neural crest cells in the mutant, although there appeared to
be slight differences in the localization of cell bodies and the overall
organization of the plexus (Figs. 6C,D). At the level of the jejunum,
differences compared to the wildtype were more prominent in the
replacement mutant, since the ENS in this area is made up of only a
few cells and a plexus is not formed (Figs. 6E,F). At caecal levels and
beyond, ENS cells were completely missing (Figs. 6G,H).
Thus, enteric neural crest cells are speciﬁed when Sox10 is
replaced by Sox100B. However, Sox100B cannot fully compensate
for the loss of Sox10 during ENS development. It is intriguing that the
defect in the Sox100B replacement mutant is much less severe than in
the Sox8 replacement or in the Sox10aa1 mutant, and slightly less
severe than in the Sox10ΔK2 mutant (Table 1), arguing that Sox100B
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the hypomorphic Sox10mutants (Kellerer et al., 2006; Schreiner et al.,
2007).
Ability of Sox100B to rescue sympathetic nervous system and adrenal
gland development in the absence of Sox10
Sympathetic nervous system defects in Sox10-deﬁcient mice are
most pronounced in caudal regions (Britsch et al., 2001; Reiprich et
al., 2008). Thus, we focused on the caudal part of the sympathetic
ganglion chain to analyze the ability of Sox100B to substitute for
Sox10 in the sympathetic nervous system. Conﬁrming the replace-
ment, Sox10 was readily detected in wildtype sympathetic ganglia
but not in the mutant (Figs. 7A,F,K,P). Instead, sympathetic ganglia
in the mutant but not in the wildtype contained Sox100B-positive
cells (Figs. 7B,G,L,Q). Immunohistochemistry revealed expression ofFig. 7. Development of sympathetic ganglia in Sox10Sox100B/Sox100B embryos. Immunohistoche
and Sox10Sox100B/Sox100B (KI, panels F–J,P–T) embryos at 12.5 dpc (A–J) and 18.5 dpc (K–
Sox100B (B,G,L,Q), Tubb3 (C,H,M,R), Phox2b (D,I,N,S) and TH (E,J,O,T). The scale bar in A is
Phox2b (U,V) and TH (W,X) was quantiﬁed in wildtype (WT) and Sox10Sox100B/Sox100B (KI)
counted for Phox2b, whereas the immunoreactive area was determined in µm2×103 for T
signiﬁcant differences of Pb0.01 (**) and Pb0.001 (***) are shown above each bar as deterpanneuronal markers such as β3-tubulin (Tubb3, Figs. 7C,H,M,R), and
also of adrenergic neuronal markers such as Phox2b (Figs. 7D,I,N,S) and
tyrosine hydroxylase (TH, Figs. 7E,J,O,T) in sympathetic ganglia of both
wildtype and the replacement mutant at 12.5 dpc and at 18.5 dpc.
However, at 12.5 dpc, the number of Phox2b expressing cells was
reduced in the mutant to 13 % of wildtype numbers (Fig. 7U). Even
at 18.5 dpc, mutant ganglia contained only 65 % of Phox2b-positive
cells in wildtype ganglia (Fig. 7V). Size of sympathetic ganglia
(determined as the TH-positive area) was also signiﬁcantly reduced in
the replacementmutantwithmutant ganglia occupying only 29% of the
area of wildtype ganglia at 12.5 dpc and 47 % at 18.5 dpc (Figs. 7W,X).
These results argue that initial formation and early development of
sympathetic ganglia is more impaired in mice homozygous for
the Sox100B replacement allele than their later development and
maintenance. Sox100B replacement mice resemble much more Sox8
replacementmice than Sox10ΔK2 and Sox10aa1mutantswhich exhibitmical staining of sympathetic ganglia was performed on wildtype (WT, panels A–E,K–O)
T) in caudal parts of the sympathetic chain using antibodies against Sox10 (A,F,K,P),
valid for A–J and the one in K for K–T. Both correspond to 50 µm. (U–X) Expression of
sympathetic ganglia at 12.5 dpc (U,W) and 18.5 dpc. (V,X) Immunoreactive cells were
H as described (Reiprich et al., 2008). Data are presented as mean±SEM. Statistically
mined by the Student's t test.
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(Table 1).
Defects were also detected in the developing adrenal medulla
which like the sympathetic nervous system develops from a
sympathoadrenal precursor cell population. At 12.5 dpc, the location
of the adrenal gland is marked by SF-1 expressing cells of the future
adrenal cortex (Fig. 8A). At this age, we already observed a slight
decrease in TH-positive precursor cells (Fig. 8A). By 18.5 dpc, TH-
positive cells in the mutant adrenal medulla remained reduced in
number (Fig. 8B). In Sox100B replacement mice, TH-positive cells
make up only 9% of the area of the adrenal gland in contrast to the
wildtype where TH-positive cells cover 14.5% of the gland (Fig. 8C).
Taking into account, however, that an adrenal medulla is completely
lacking in Sox10-deﬁcient mice and very strongly reduced in the
Sox10ΔK2 and Sox10aa1mutants, the ability of Sox100B to rescue this
defect is substantial and at least as good as the mammalian Sox8
protein (Table 1) (Reiprich et al., 2008).Ability of Sox100B to rescue dorsal root ganglion development in the
absence of Sox10
An additional defect in Sox10-deﬁcient mice is apparent in the
dorsal root ganglia (DRG). These PNS structures originally develop
in the absence of Sox10, but already start to degenerate at 12.5 dpc
(Britsch et al., 2001). Satellite glia are completely absent from DRG,
and neurogenesis is also impaired in Sox10-deﬁcient mice. In the
Sox100B replacement mutant satellite glia were present in ganglia
throughout development. At both 12.5 dpc and at 18.5 dpc, glial
cells were marked by Sox100B which replaced Sox10 expression in
wildtype glia (Figs. 9A,B,E,F,I,J,M,N). In addition, glial cells in
the replacement mutant and in the wildtype were both positive
for B-FABP which represents the earliest available glial marker in
the PNS (Figs. 9C,G,K,O). Neurons were also present in the DRG of
the Sox100B replacement mutant as evident from NeuN staining
(Figs. 9D,H,L,P). Again this shows that Sox100B is at least partially
capable of substituting for Sox10 during DRG development.
Quantiﬁcation revealed that the number of glial cells was only
slightly reduced at 12.5 dpc to 78% of wildtype numbers (Fig. 9Q)
and indistinguishable from the wildtype at 18.5 dpc (Fig. 9R). In
contrast, neuron numbers were reduced to approximately 40% inFig. 8. Development of the adrenal gland in Sox10Sox100B/Sox100B embryos. Immunohistochemic
(KI) embryos at 12.5 dpc (A) and 18.5 dpc (B) using antibodies against TH and SF-1. (C) TH sta
adrenal gland in both genotypes. Three adrenal glands were used per genotype for quantiﬁc
statistically signiﬁcant (***, Pb0.001) as determined by the Student's t test. Scale bars in A andthe Sox100B replacement mutant both at 12.5 dpc and 18.5 dpc
(Figs. 9S,T) and are therefore predominantly responsible for the
reduced overall size of the ganglia. It thus appears that Sox100B
expressing satellite glia in the replacement mutant cannot support
DRG neurons as efﬁciently as Sox10 expressing glia in the wildtype.
In contrast to the Sox8 replacement mutant (Kellerer et al., 2006),
DRG development is thus not completely rescued in the Sox100B
replacement mutant (Table 1). The Sox100B replacement phenotype
is also stronger than observed in Sox10aa1 mutants where only
mild alterations in DRG are visible at late stages of embryonic
development (Schreiner et al., 2007). In terms of severity, the DRG
defect in Sox100B replacement mice is most similar to that
observed in the Sox10ΔK2 mutant (Schreiner et al., 2007).
Sox100B, however, remains expressed in DRG, whereas DRG
degeneration in the Sox10ΔK2 mutant is preceded by disappearance
of the mutant Sox10 protein from the ganglia.Ability of Sox100B to rescue Schwann cell development in the absence of
Sox10
Glial development throughout the PNS requires Sox10. This not
only includes satellite glia in the DRG but also Schwann cells along the
nerves (Britsch et al., 2001). Analysis of the Sox100B replacement
mutant reveals that Schwann cells develop normally (Fig. 10 and data
not shown). At 18.5 dpc, for example, there are as many Sox100B-
positive cells along the peripheral nerve in the Sox100B replacement
mutant as there are Sox10-positive cells in thewildtype (Figs. 10A,B,C,
D,K). A signiﬁcant percentage of these Schwann cells show Oct6
expression which is indicative of their progression from an immature
Schwann cell to a promyelinating Schwann cell (Figs. 10E,F). The
number of Oct6-positive cells is comparable between wildtype and
mutant (Fig. 10L). Also comparable is the fraction of Schwann cells
expressing Krox-20 at 18.5 dpc, indicating that Schwann cells have
initiated theﬁnal phase of differentiation andmyelination on schedule
in the Sox100B replacement mutant (Figs. 10G,H). In agreement,
myelin markers such asMBP are expressed in the mutant in a pattern
and intensity that is comparable to thewildtype (Figs. 10I,J). Similar to
Sox8 (Kellerer et al., 2006), Sox100B can effectively rescue the
Schwann cell defect in Sox10-deﬁcient mice (Table 1). Sox100B is
thus much more effective in driving Schwann cell development thanal staining of the adrenal glandwas performed onwildtype (WT) and Sox10Sox100B/Sox100B
ining at 18.5 dpc was also used to calculate the relative contribution of the medulla to the
ations. Data are presented as mean±SEM. The difference between the two genotypes is
B correspond to 50 µm. Both are valid for all panels.
Fig. 9. Analysis of DRG in Sox10Sox100B/Sox100B embryos. Immunohistochemistry was carried out on transverse sections through DRG of wildtype (WT, panels A–D,I–L) and
Sox10Sox100B/Sox100B (KI, panels E–H,M–P) embryos at 12.5 dpc (A–H) and 18.5 dpc (I–P) in thoracic regions using antibodies against Sox10 (A,E,I,M), Sox100B (B,F,J,N), the glial
marker B-FABP (C,G,K,O) and the neuronal marker NeuN (D,H,L,P). The spinal cord is to the right of the DRG. The scale bar in A is valid for A–H and the one in I for I–P. Both
correspond to 100 µm. (Q–T) Expression of Sox10/Sox100B (Q,R) and NeuN (S,T) was quantiﬁed in wildtype (WT) and Sox10Sox100B/Sox100B (KI) DRG at 12.5 dpc (Q,S) and 18.5 dpc
(R,T) by counting the immunoreactive cells. Data are presented as mean±SEM. Statistically signiﬁcant differences of Pb0.001 (***) are shown above each bar as determined by the
Student's t test.
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Table 1
Summary of the rescuing capacity of different mutant Sox10 alleles.
Development of… Rescue by allele
Sox10Sox100B Sox10Sox8 Sox10aa1 Sox10ΔK2
Early neural crest + + + +
Melanocytes − − − ±/−
ENS ± − − ±/−
Sympathetic ganglia (caudal) ± ± − −
Adrenal medulla ± ± − −
DRG ± + +/± ±
Schwann cells + + ± ±
Oligodendrocytes + − + ±
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domain (Schreiner et al., 2007).
Ability of Sox100B to rescue oligodendrocyte development in the absence
of Sox10
In the developing CNS, Sox10 is restricted to the myelin-forming
oligodendrocytes and their precursors, and terminal differentiation of
oligodendrocytes is impaired in Sox10-deﬁcient mice (Stolt et al.,
2002). In the Sox100B replacement mutant, Sox100B was ﬁrst
detected in the ventral spinal cord around 12.5 dpc in the vicinity of
the ventricular zone of the pMN domain. This corresponds both inFig. 10. Peripheral nerve development in Sox10Sox100B/Sox100B embryos. Immunohis-
tological analysis of spinal nerves from wildtype (WT, panels A,C,E,G,I) and
Sox10Sox100B/Sox100B (KI, panels B,D,F,H,J) embryos at 18.5 dpc was carried out using
antibodies against Sox10 (A,B), Sox100B (C,D), Oct6 (E,F) and Krox20 (G,H). MBP
expression was additionally visualized in both genotypes by in situ hybridization (I,J).
The scale bar in A is also valid for B–H, whereas the scale bar in I is also valid for J. Both
correspond to 50 µm. (K,L) The number of cells immunoreactive for Sox10/Sox100B
(K) and Oct6 (L) was quantiﬁed in wildtype (WT) and Sox10Sox100B/Sox100B (KI) spinal
nerves at 18.5 dpc. Data are presented as mean±SEM. Differences between genotypes
were not statistically signiﬁcant as determined by the Student's t test.
+, complete rescue; ±, substantial partial rescue; −, minor to no rescue.
Data for the Sox10Sox8, Sox10aa1 and the Sox10ΔK2 alleles are compiled from Kellerer et al.
(2006), Reiprich et al. (2008) and Schreiner et al. (2007).timing and pattern to the normal onset of Sox10 expression in the
wildtype (Fig. 11A). Similar to Sox10 in the wildtype, Sox100B
remained expressed in the oligodendrocyte precursors throughout
embryonic development until 18.5 dpc (Fig. 11B). Furthermore, the
number of cells belonging to the oligodendrocyte lineage was
comparable between wildtype and Sox100B replacement mutant
throughout embryogenesis as evident from quantiﬁcations of
Olig2 stainings, thus demonstrating that Sox100B expression does
not interfere with oligodendrocyte development (Figs. 11D,E).
Importantly, the number of terminally differentiating (i.e. MBP- and
PLP-expressing) oligodendrocytes in mutant spinal cord at 18.5 dpc
equalled those in thewildtype (Fig. 11C and data not shown). As these
cells are completely missing in spinal cords of Sox10-deﬁcient mice
(Stolt et al., 2002), we conclude that Sox100B efﬁciently rescues the
oligodendrocyte terminal differentiation defect observed in the
absence of Sox10. A similarly efﬁcient rescue was previously observed
in the Sox10aa1 mutant and, slightly less efﬁciently, in the Sox10ΔK2
mutant (Schreiner et al., 2007). Intriguingly, however, such a rescue
was not observed in the Sox8 replacement mutant (Kellerer et al.,
2006) indicating that Sox100B is a much better substitute for Sox10
during oligodendrocyte development than the mammalian SoxE
protein Sox8.
Discussion
We have studied the ability of the Drosophila SoxE protein,
Sox100B, to perform the functions of the vertebrate SoxE protein
Sox10 in cell lineages that do not exist in Drosophila. Both over-
expression studies in the chicken and gene replacement in the mouse
clearly demonstrate that Sox100B integrates well into the gene-
regulatory networks that drive early neural crest development.
Oligodendrocyte development is also indistinguishable in wildtype
and Sox100B replacement homozygotes until birth. We therefore
conclude that Sox100B and Sox10 are functionally similar.
In evolutionary terms this argues that an existing SoxE protein
could have been easily integrated into the novel regulatory networks
that drive neural crest and oligodendrocyte development. As the SoxE
protein would have been functional without major structural
alterations, a newly acquired expression domain in the neural crest
or in oligodendrocytes would per se have been sufﬁcient to endow the
SoxE protein with a pivotal regulatory role in these cell types. In
agreement with such a model, the appearance of SoxE proteins at the
neural plate border correlates with the emergence of a neural crest.
SoxE proteins are not expressed at the neural plate border in
amphioxus, a basal chordate, but are found there in the basal
agnathan vertebrates lamprey and hagﬁsh (McCauley and Bronner-
Fraser, 2006; Sauka-Spengler et al., 2007; Yu et al., 2008).
Also in agreement with this model, the SoxE proteins expressed in
the neural crest of agnathans differ from the SoxE proteins in
gnathostomes (McCauley and Bronner-Fraser, 2006; Ota et al.,
Fig. 11. Oligodendrocyte development in Sox10Sox100B/Sox100B embryos. Speciﬁcation (A), subsequent distribution of oligodendrocyte precursors (B) and terminal differentiation (C)
were analyzed on transverse spinal cord sections from the forelimb region of wildtype (WT) and Sox10Sox100B/Sox100B (KI) embryos at 12.5 dpc (A) and 18.5 dpc (B,C) by
immunohistochemistry with antibodies directed against Sox10, Sox100B and Olig2 (A,B) and by in situ hybridization with anMBP-speciﬁc probe (C). Scale bars in A, B and C are valid
for all respective panels. All correspond to 200 µm. (D,E) The number of Olig2-positive cells was quantiﬁed in wildtype (WT) and Sox10Sox100B/Sox100B (KI) spinal cords at 12.5 dpc
(D) and 18.5 dpc (E). Data are presented as mean±SEM. Differences between genotypes were not statistically signiﬁcant as determined by the Student's t test.
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from tetrapods or teleosts outside the HMG domain, and virtually no
homology between lamprey SoxE1 and SoxE2 proteins and the Sox8
and Sox10 proteins (McCauley and Bronner-Fraser, 2006). Neverthe-
less, these agnathan SoxE proteins function in neural crest develop-
ment as well as their counterparts in gnathostomes (McCauley and
Bronner-Fraser, 2006; Ota et al., 2007).
Even in gnathostomes there is some variation in the usage of
SoxE proteins with Sox8 being a major regulator of neural crest
development only in amphibians (O'Donnell et al., 2006). Taking
into account that all SoxE proteins tested so far are equally capable
of driving early neural crest development under widely varying
experimental conditions (Cheung and Briscoe, 2003; Kellerer et al.,
2006; Taylor and LaBonne, 2005) there is overwhelming evidence
that SoxE proteins were co-opted to the neural crest gene-
regulatory network by changes in their expression without an
immediate need for altered biochemical properties. The recent
identiﬁcation of multiple enhancers in the vicinity of the mouse
Sox10 gene may be instrumental in determining how this novel
expression was acquired (Antonellis et al., 2008; Werner et al.,
2007).
Our data also suggest that SoxE proteins may have been similarly
co-opted to the gene-regulatory network that drives oligodendrocyte
development. Considering how little is known about the evolution of
oligodendrocytes and the components of the oligodendrocyte gene-regulatory network, our data provide one of the ﬁrst insights into this
interesting topic.
In mice homozygous for the Sox100B replacement allele, neural
crest cells are capable of giving rise to all types of derivatives that
normally require Sox10 including melanoblasts, cells of the enteric
and sympathetic nervous systems, cells of the adrenal medulla, and
peripheral glia (Britsch et al., 2001; Herbarth et al., 1998; Kapur,
1999; Reiprich et al., 2008; Southard-Smith et al., 1998). The
phenotypic rescue is, however, not complete since defects are
observed during later stages of neural crest development (Table 1).
Development of the melanocyte lineage was most severely impaired
and substantial defects were also evident in the enteric and
sympathetic nervous systems, whereas other parts of the PNS,
including DRG, were less strongly affected. In contrast, Schwann cell
development is comparatively normal with terminally differentiating
myelinating Schwann cells detected at birth in homozygous Sox100B
replacement mutants. This argues that Sox10 and its Drosophila
ortholog are similar but not identical in their properties and
functions. They may, for instance, interact with different partner
proteins or be differentially receptive to signal-dependent posttrans-
lational modiﬁcations. Again this ﬁnding can be interpreted in
evolutionary terms and suggests that once co-opted to a neural crest-
speciﬁc gene-regulatory network, vertebrate SoxE proteins have
consecutively undergone alterations in their biochemical properties,
interaction capacities, and signal responsiveness to better suit their
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of the neural crest into many different types of derivatives required
adaptive changes in SoxE protein structure. This scenario would also
allow co-expressed and originally identical SoxE proteins to diversify
structurally and functionally with Sox9 becoming essential for the
development of ectomesenchymal cell lineages in the cranial neural
crest and Sox10 playing numerous decisive roles in the various non-
ectomesenchymal neural crest lineages. These increasing adapta-
tions, sub- and neofunctionalizations could contribute to the
eventual lockdown of the regulatory network (Erwin and Davidson,
2009).
In this respect, it is also interesting to compare Sox100B and the
previously studied mammalian Sox8 protein in their ability to
provide Sox10-speciﬁc functions (Kellerer et al., 2006). In general,
both proteins are fairly good substitutes for Sox10. However, there
are also clear differences between the phenotypes observed with
each protein. Sox8 can rescue development of DRG and sympathetic
ganglia more efﬁciently than Sox100B, whereas Sox100B is clearly a
better substitute for Sox10 during ENS development. Additionally,
Sox100B can induce terminal differentiation of oligodendrocytes as
efﬁciently as Sox10, whereas Sox8 is severely impaired in this
function. Taking into account that Sox8 is co-expressed with Sox10
in developing ENS and oligodendrocytes and that mild defects that
occur in these cell lineages in Sox10+/lacZ mice can be substantially
aggravated by additional loss of Sox8 (Maka et al., 2005; Stolt et al.,
2004), it is intriguing and surprising that Sox100B is the better
substitute. It may point to the fact, however, that Sox8 and Sox10
have undergone some degree of subfunctionalization during ENS
and oligodendrocyte development. If this is the case, it suggests that
all the essential functions have segregated with Sox10 and the less
important functions with Sox8. The resulting divergent adaptations
in protein structure may now, however, prevent Sox8 from fully
replacing Sox10. Sox100B, in contrast, lacks these structural
specializations and might therefore be a better, although not perfect
substitute. If this is the case, we expect that Sox100B will be a
better substitute for Sox9 during cranial neural crest development
than Sox10.
The fact that the invertebrate SoxE protein is as efﬁcient in
replacing Sox10 as the mammalian Sox8 is also intriguing with
respect to structural considerations. There is clearly much greater
overall sequence similarity between Sox10 and Sox8 than between
Sox10 and Sox100B, in particular within the dimerization, K2, and
carboxy-terminal transactivation domains. Sox10 alleles with an
inactivated dimerization domain or deleted K2 domain have
furthermore shown that these domains are required for proper
function (Schreiner et al., 2007). With exception of the melanocyte
defect in the ΔK2 mutant, the corresponding hypomorphic mouse
mutants usually have developmental defects that are at least as
severe as and often more severe than those in mice homozygous for
the Sox100B replacement allele. This clearly argues that the
functions of the mammalian dimerization and K2 domains must at
least in part be conserved in Sox100B. Our biochemical studies
indeed conﬁrmed that Sox100B is capable of DNA-dependent dimer
formation and possesses transactivation capacity. A deﬁnitive
biochemical test for K2 domain activity is currently not available
and neither sequence alignments nor structural prediction algo-
rithms have so far revealed a K2-like domain in Sox100B. Yet, a
functional equivalent must be present. Our ﬁndings may thus
inspire further comparative biochemical studies in which function-
ally important residues and conformational determinants of SoxE
proteins are deﬁned. More importantly, however, they shed light on
the evolution of gene-regulatory networks and provide strong
evidence that the role of SoxE proteins in neural crest and
oligodendrocyte development is ancestral in vertebrates and was
acquired through altered expression and co-option to novel gene-
regulatory networks.Acknowledgments
Anna Hartwig and Jana Kriesch are acknowledged for their expert
technical assistance. We thank J. Barbas, C. Goridis, M. Goulding,
K. Morohashi, D. Rowitch, T. Müller and C. Birchmeier for the gift of
antibodies and in situ probes. This workwas supported by grants from
the Deutsche Forschungsgemeinschaft to M.W. (SFB473 and
We1326/8-1).References
Antonellis, A., Huynh, J.L., Lee-Lin, S.-Q., Vinton, R.M., Renaud, G., Loftus, S.K., Elliot, G.,
Wolfsberg, T.G., Green1, E.D., McCallion, A.S., Pavan, W.J., 2008. Identiﬁcation of
neural crest and glial enhancers at the mouse Sox10 locus through transgenesis in
zebraﬁsh. PLoS Genet. 4, e1000174.
Baker, C.V.H., 2008. The evolution and elaboration of vertebrate neural crest cells. Curr.
Opin. Genet. Dev. 18, 536–543.
Bondurand, N., Pingault, V., Goerich, D.E., Lemort, N., Sock, E., Le Caignec, C., Wegner, M.,
Goossens, M., 2000. Interaction between SOX10, PAX3 and MITF, three genes
implicated in Waardenburg syndrome. Hum. Mol. Genet. 9, 1907–1917.
Britsch, S., Goerich, D.E., Riethmacher, D., Peirano, R.I., Rossner, M., Nave, K.A.,
Birchmeier, C., Wegner, M., 2001. The transcription factor Sox10 is a key regulator
of peripheral glial development. Genes Dev. 15, 66–78.
Cheung, M., Briscoe, J., 2003. Neural crest development is regulated by the transcription
factor Sox9. Development 130, 5681–5693.
Cheung, M., Chaboissier, M.-C., Mynett, A., Hirst, E., Schedl, A., Briscoe, J., 2005. The
transcriptional control of trunk neural crest induction, survival, and delamination.
Dev. Cell 8, 179–192.
DeFalco, T.J., Verney, G., Jenkins, A.B., McCaffery, J.M., Russell, S., Van Doren, M., 2003.
Sex-speciﬁc apoptosis regulates sexual dimorphism in the Drosophila embryonic
gonad. Dev. Cell 5, 205–216.
DeFalco, T., Camara, N., Le Bras, S., Van Doren, M., 2008. Nonautonomous sex
determination controls sexually dimorphic development of the Drosophila gonad.
Dev. Cell 14, 275–286.
Dottori, M., Gross, M.K., Labosky, P., Goulding, M., 2001. The winged-helix transcription
factor Foxd3 suppresses interneuron differentiation and promotes neural crest cell
fate. Development 128, 4127–4138.
Erwin, D.H., Davidson, E.H., 2009. The evolution of hierarchical gene regulatory
networks. Nat. Rev. Genet. 10, 141–148.
Finzsch, M., Stolt, C.C., Lommes, P., Wegner, M., 2008. Sox9 and Sox10 inﬂuence survival
and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF
receptor alpha expression. Development 135, 637–646.
Friedrich, R., Schlierf, B., Tamm, E.R., Bösl, M.R., Wegner, M., 2005. The class III POU
domain protein Brn-1 can fully replace the related Oct-6 during Schwann cell
development and myelination. Mol. Cell. Biol. 25, 1821–1829.
Gans, C., Northcutt, R.G., 1983. Neural crest and the origin of vertebrates: a new head.
Science 220, 268–274.
Guth, S.I.E., Wegner, M., 2008. Having it both ways: Sox protein function between
conservation and innovation. Cell. Mol. Life Sci. 65, 3000–3018.
Hamburger, H., Hamilton, H.L., 1953. A series of normal stages in the development of
the chick embryo. J. Morphol. 88, 49–92.
Herbarth, B., Pingault, V., Bondurand, N., Kuhlbrodt, K., Hermans-Borgmeyer, I., Puliti,
A., Lemort, N., Goossens, M., Wegner, M., 1998. Mutation of the Sry-related Sox10
gene inDominant megacolon, a mousemodel for human Hirschsprung disease. Proc.
Natl. Acad. Sci. U. S. A. 95, 5161–5165.
Hui Yong Loh, S., Russell, S., 2000. A Drosophila group E Sox gene is dynamically
expressed in the embryonic alimentary canal. Mech. Dev. 93, 185–188.
Kapur, R.P., 1999. Earlydeathofneural crest cells is responsible for total enteric aganglionosis
in Sox10(Dom)/Sox10(Dom) mouse embryos. Pediatr. Dev. Pathol. 2, 559–569.
Kellerer, S., Schreiner, S., Stolt, C.C., Bösl, M.R.,Wegner,M., 2006. Functional equivalency of
transcription factors Sox8 and Sox10 is tissue-speciﬁc. Development 133, 2875–2886.
Kim, J., Lo, L., Dormand, E., Anderson, D.J., 2003. SOX10 maintains multipotency and
inhibits neuronal differentiation of neural crest stem cells. Neuron 38, 17–31.
Kuhlbrodt, K., Herbarth, B., Sock, E., Hermans-Borgmeyer, I., Wegner, M., 1998. Sox10, a
novel transcriptional modulator in glial cells. J. Neurosci. 18, 237–250.
Ludwig, A., Rehberg, S., Wegner, M., 2004a. Melanocyte-speciﬁc expression of
dopachrome tautomerase is dependent on synergistic gene activation by the
Sox10 and Mitf transcription factors. FEBS Lett. 556, 236–244.
Ludwig, A., Schlierf, B., Schardt, A., Nave, K.A., Wegner, M., 2004b. A Sox10 rtTA mouse
line for tetracycline-inducible expression of transgenes in neural crest cells and
oligodendrocytes. Genesis 40, 171–175.
Maka, M., Stolt, C.C., Wegner, M., 2005. Identiﬁcation of Sox8 as a modiﬁer gene in a
mouse model of Hirschsprung disease reveals underlying molecular defect. Dev.
Biol. 277, 155–169.
McCauley, D.W., Bronner-Fraser, M., 2006. Importance of SoxE in neural crest
development and the evolution of the pharynx. Nature 441, 750–752.
McKeown, S.J., Lee, V.M., Bronner-Fraser, M., Newgreen, D.F., Farlier, P.G., 2005. Sox10
overexpression induces neural crest-like cells from all dorsoventral levels of the
neural tube but inhibits differentiation. Dev. Dyn. 233, 430–444.
Nanda, S., DeFalco, T.J., Loh, S.H., Phochanukul, N., Camara, N., Van Doren, M., Russell, S.,
2009. Sox100B, aDrosophila group E Sox-domain gene, is required for somatic testis
differentiation. Sex Dev. 3, 26–37.
281F. Cossais et al. / Developmental Biology 341 (2010) 267–281O'Donnell, M., Hong, C.S., Huang, X., Delnicki, R.J., Saint-Jeannet, J.P., 2006. Functional
analysis of Sox8 during neural crest development in Xenopus. Development 133,
3817–3826.
Ota, K.G., Kuraku, S., Kuratani, S., 2007. Hagﬁsh embryology with reference to the
evolution of the neural crest. Nature 446, 672–675.
Peirano, R.I., Wegner, M., 2000. The glial transcription factor Sox10 binds to DNA both
as monomer and dimer with different functional consequences. Nucleic Acids Res.
28, 3047–3055.
Peirano, R.I., Goerich, D.E., Riethmacher, D., Wegner, M., 2000. Protein zero
expression is regulated by the glial transcription factor Sox10. Mol. Cell. Biol.
20, 3198–3209.
Perez-Alcala, S., Nieto,M.A., Barbas, J.A., 2004. LSox5 regulatesRhoBexpression in theneural
tube and promotes generation of the neural crest. Development 131, 4455–4465.
Poirot, O., O'Toole, E., Notredame, C., 2003. Tcoffee@igs: A web server for computing,
evaluating and combining multiple sequence alignments. Nucleic Acids Res. 31,
3503–3506.
Pusch, C., Hustert, E., Pfeifer, D., Südbeck, P., Kist, R., Roe, B., Wang, Z., Balling, R., Blin, N.,
Scherer, G., 1998. The SOX10/Sox10 gene from human and mouse: sequence,
expression, and transactivation by the encoded HMG domain transcription factor.
Hum. Genet. 103, 115–123.
Reiprich, S., Stolt, C.C., Schreiner, S., Parlato, R., Wegner, M., 2008. SoxE proteins are
differentially required in mouse adrenal gland development. Mol. Biol. Cell 19,
1575–1586.
Sauka-Spengler, T., Meulemans, D., Jones, M., Bronner-Fraser, M., 2007. Ancient
evolutionary origin of the neural crest gene regulatory network. Dev. Cell 13,
405–420.
Schepers, G.E., Bullejos, M., Hosking, B.M., Koopman, P., 2000. Cloning and character-
isation of the sry-related transcription factor gene sox8. Nucleic Acids Res. 28,
1473–1480.
Scherer-Singler, U., Vincent, S.R., Kimura, H., McGeer, E.G., 1983. Demonstration of a
unique population of neurons with NADPH-diaphorase histochemistry. J. Neurosci.
Methods 9, 229–234.Schlierf, B., Ludwig, A., Klenovsek, K., Wegner, M., 2002. Cooperative binding of Sox10
to DNA: requirements and consequences. Nucleic Acids Res. 30, 5509–5516.
Schreiner, S., Cossais, F., Fischer, K., Scholz, S., Bösl, M.R., Holtmann, B., Sendtner, M.,
Wegner, M., 2007. Hypomorphic Sox10 alleles reveal novel protein functions and
unravel developmental differences in glial lineages. Development 134, 3271–3281.
Southard-Smith, E.M., Kos, L., Pavan, W.J., 1998. Sox10 mutation disrupts neural crest
development in Dom Hirschsprung mouse model. Nat. Genet. 18, 60–64.
Stolt, C.C., Rehberg, S., Ader, M., Lommes, P., Riethmacher, D., Schachner, M., Bartsch, U.,
Wegner, M., 2002. Terminal differentiation of myelin-forming oligodendrocytes
depends on the transcription factor Sox10. Genes Dev. 16, 165–170.
Stolt, C.C., Lommes, P., Sock, E., Chaboissier, M.-C., Schedl, A., Wegner, M., 2003. The
Sox9 transcription factor determines glial fate choice in the developing spinal cord.
Genes Dev. 17, 1677–1689.
Stolt, C.C., Lommes, P., Friedrich, R.P., Wegner, M., 2004. Transcription factors Sox8 and
Sox10 perform non-equivalent roles during oligodendrocyte development despite
functional redundancy. Development 131, 2349–2358.
Stolt, C.C., Schmitt, S., Lommes, P., Sock, E., Wegner, M., 2005. Impact of transcription
factor Sox8 on oligodendrocyte speciﬁcation in the mouse embryonic spinal cord.
Dev. Biol. 281, 323–331.
Südbeck, P., Schmitz, M.L., Baeuerle, P.A., Scherer, G., 1996. Sex reversal by loss of the
C-terminal transactivation domain of human SOX9. Nat. Genet. 13, 230–232.
Taylor, K.M., LaBonne, C., 2005. SoxE factors function equivalently during neural crest
and inner ear development and their activity is regulated by SUMOylation. Dev. Cell
9, 593–603.
Werner, T., Hammer, A., Wahlbuhl, M., Bösl, M.R., Wegner, M., 2007. Multiple conserved
regulatory elements with overlapping functions determine Sox10 expression in
mouse embryogenesis. Nucleic Acids Res. 35, 6526–6538.
Yu, J.K., Meulemans, D., McKeown, S.J., Bronner-Fraser, M., 2008. Insights from the
amphioxus genome on the origin of vertebrate neural crest. Genome Res. 18,
1127–1132.
Zalc, B., Goujet, D., Colman, D., 2008. The origin of the myelination program in
vertebrates. Curr. Biol. 18, R511–512.
